These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 24356250

  • 1. Comprehensive overview of definitions for optical coherence tomography-based plaque and stent analyses.
    Di Vito L, Yoon JH, Kato K, Yonetsu T, Vergallo R, Costa M, Bezerra HG, Arbustini E, Narula J, Crea F, Prati F, Jang IK, COICO group (Consortium of Investigators for Coronary OCT).
    Coron Artery Dis; 2014 Mar; 25(2):172-85. PubMed ID: 24356250
    [Abstract] [Full Text] [Related]

  • 2. Optical coherence tomography to evaluate coronary stent implantation and complications.
    Hayat U, Thondapu V, Ul Haq MA, Foin N, Jang IK, Barlis P.
    Coron Artery Dis; 2015 Aug; 26 Suppl 1():e55-68. PubMed ID: 26247272
    [Abstract] [Full Text] [Related]

  • 3. Clinical Impact of OCT Findings During PCI: The CLI-OPCI II Study.
    Prati F, Romagnoli E, Burzotta F, Limbruno U, Gatto L, La Manna A, Versaci F, Marco V, Di Vito L, Imola F, Paoletti G, Trani C, Tamburino C, Tavazzi L, Mintz GS.
    JACC Cardiovasc Imaging; 2015 Nov; 8(11):1297-305. PubMed ID: 26563859
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of long-term follow-up with neointimal coverage and stent apposition after sirolimus-eluting stent implantation by optical coherence tomography.
    Li S, Gai L, Yang T, Zhang L, Xu X, Bai Q, Xu H, Wang Y.
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):768-75. PubMed ID: 22639418
    [Abstract] [Full Text] [Related]

  • 5. Initial findings of impact of strut width on stent coverage and apposition of sirolimus-eluting stents assessed by optical coherence tomography.
    Nakatani S, Nishino M, Taniike M, Makino N, Kato H, Egami Y, Shutta R, Tanouchi J, Yamada Y.
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):776-81. PubMed ID: 22517601
    [Abstract] [Full Text] [Related]

  • 6. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
    Gogas BD, Garcia-Garcia HM, Onuma Y, Muramatsu T, Farooq V, Bourantas CV, Serruys PW.
    JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
    [Abstract] [Full Text] [Related]

  • 7. Neoatherosclerosis in Patients With Coronary Stent Thrombosis: Findings From Optical Coherence Tomography Imaging (A Report of the PRESTIGE Consortium).
    Joner M, Koppara T, Byrne RA, Castellanos MI, Lewerich J, Novotny J, Guagliumi G, Xhepa E, Adriaenssens T, Godschalk TC, Malik N, Alfonso F, Tada T, Neumann FJ, Desmet W, Ten Berg JM, Gershlick AH, Feldman LJ, Massberg S, Kastrati A, Prevention of PRESTIGE Investigators.
    JACC Cardiovasc Interv; 2018 Jul 23; 11(14):1340-1350. PubMed ID: 30025727
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
    Fujino Y, Attizzani GF, Bezerra HG, Wang W, Tahara S, Yamamoto H, Chamie D, Kanaya T, Mehanna E, Takagi K, Nakamura S, Costa MA.
    JACC Cardiovasc Interv; 2013 Oct 23; 6(10):1035-45. PubMed ID: 24156964
    [Abstract] [Full Text] [Related]

  • 10. Two-week interval optical coherence tomography: imaging evidence on neointimal coverage completion after implantation of the Endeavor zotarolimus-eluting stent.
    Nishinari M, Shimohama T, Tojo T, Shiono T, Shinagawa H, Kameda R, Aoyama N, Izumi T.
    Catheter Cardiovasc Interv; 2013 Dec 01; 82(7):E871-8. PubMed ID: 23873677
    [Abstract] [Full Text] [Related]

  • 11. Validation and application of OCT tissue attenuation index for the detection of neointimal foam cells.
    Nicol P, Hoppman P, Euller K, Xhepa E, Lenz T, Rai H, Jinnouchi H, Bulin A, Castellanos MI, Lahmann AL, Koppara T, Kastrati A, Joner M.
    Int J Cardiovasc Imaging; 2021 Jan 01; 37(1):25-35. PubMed ID: 32761285
    [Abstract] [Full Text] [Related]

  • 12. Potential Mechanisms of In-stent Neointimal Atherosclerotic Plaque Formation.
    Zhang DM, Chen SL.
    J Cardiovasc Pharmacol; 2021 Sep 01; 78(3):388-393. PubMed ID: 34029271
    [Abstract] [Full Text] [Related]

  • 13. Multimodality visualization with 3-dimensional reconstruction of neointimal plaque rupture after bare-metal stent implantation.
    Sudo M, Hiro T, Takayama T, Iida K, Nishida T, Kawano T, Kanai T, Higuchi Y, Hirayama A.
    JACC Cardiovasc Interv; 2014 Oct 01; 7(10):e163-5. PubMed ID: 25240542
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Clinical Impact of Suboptimal Stenting and Residual Intrastent Plaque/Thrombus Protrusion in Patients With Acute Coronary Syndrome: The CLI-OPCI ACS Substudy (Centro per la Lotta Contro L'Infarto-Optimization of Percutaneous Coronary Intervention in Acute Coronary Syndrome).
    Prati F, Romagnoli E, Gatto L, La Manna A, Burzotta F, Limbruno U, Versaci F, Fabbiocchi F, Di Giorgio A, Marco V, Ramazzotti V, Di Vito L, Trani C, Porto I, Boi A, Tavazzi L, Mintz GS.
    Circ Cardiovasc Interv; 2016 Dec 01; 9(12):. PubMed ID: 27965297
    [Abstract] [Full Text] [Related]

  • 16. Calcified Neoatherosclerosis Causing "Undilatable" In-Stent Restenosis: Insights of Optical Coherence Tomography and Role of Rotational Atherectomy.
    Bastante T, Rivero F, Cuesta J, Alfonso F.
    JACC Cardiovasc Interv; 2015 Dec 28; 8(15):2039-2040. PubMed ID: 26738675
    [No Abstract] [Full Text] [Related]

  • 17. Optical coherence tomography characteristics of in-stent restenosis after drug-eluting stent implantation: a novel classification and its clinical significance.
    Yamamoto W, Fujii K, Otsuji S, Takiuchi S, Kakishita M, Ibuki M, Hasegawa K, Ishibuchi K, Tamaru H, Yasuda S, Ishii R, Nakabayashi S, Kusumoto H, Higashino Y.
    Heart Vessels; 2020 Jan 28; 35(1):38-45. PubMed ID: 31250131
    [Abstract] [Full Text] [Related]

  • 18. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
    Kim JS, Jang IK, Fan C, Kim TH, Kim JS, Park SM, Choi EY, Lee SH, Ko YG, Choi D, Hong MK, Jang Y.
    JACC Cardiovasc Interv; 2009 Dec 28; 2(12):1240-7. PubMed ID: 20129551
    [Abstract] [Full Text] [Related]

  • 19. Restenosis After Drug-Eluting Stent Implantation in a Patient With Polycythemia Vera: Optical Coherence Tomography and Pathological Findings.
    Fujino A, Hao H, Kajimoto N, Kawakami R, Imanaka T, Fujii K, Abe T, Ishihara M, Hirota S.
    JACC Cardiovasc Interv; 2015 Jun 28; 8(7):e111-2. PubMed ID: 26003023
    [No Abstract] [Full Text] [Related]

  • 20. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC, Otto S, Gassdorf J, Janiak F, Danzer C, Ferrari M, Figulla HR.
    EuroIntervention; 2011 May 28; 7 Suppl K():K93-9. PubMed ID: 22027737
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.